NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.


Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
01 10 2019
Historique:
entrez: 8 10 2019
pubmed: 8 10 2019
medline: 15 7 2020
Statut: ppublish

Résumé

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.

Identifiants

pubmed: 31590151
doi: 10.6004/jnccn.2019.0049
pii: jnccninsmm1710
doi:
pii:

Types de publication

Guideline Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1154-1165

Auteurs

Shaji K Kumar (SK)

Mayo Clinic Cancer Center.

Natalie S Callander (NS)

University of Wisconsin Carbone Cancer Center.

Jens Hillengass (J)

Roswell Park Comprehensive Cancer Center.

Michaela Liedtke (M)

Stanford Cancer Institute.

Muhamed Baljevic (M)

Fred & Pamela Buffett Cancer Center.

Erica Campagnaro (E)

University of Michigan Rogel Cancer Center.

Jorge J Castillo (JJ)

Dana-Farber/Brigham and Women's Cancer Center.

Jason C Chandler (JC)

St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.

Robert F Cornell (RF)

Vanderbilt-Ingram Cancer Center.

Caitlin Costello (C)

UC San Diego Moores Cancer Center.

Yvonne Efebera (Y)

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Matthew Faiman (M)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Alfred Garfall (A)

Abramson Cancer Center at the University of Pennsylvania.

Kelly Godby (K)

O'Neal Comprehensive Cancer Center at UAB.

Leona Holmberg (L)

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

Myo Htut (M)

City of Hope National Medical Center.

Carol Ann Huff (CA)

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Yubin Kang (Y)

Duke Cancer Institute.

Ola Landgren (O)

Memorial Sloan Kettering Cancer Center.

Ehsan Malek (E)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Thomas Martin (T)

UCSF Helen Diller Family Comprehensive Cancer Center.

James Omel (J)

Patient Advocate.

Noopur Raje (N)

Massachusetts General Hospital Cancer Center.

Douglas Sborov (D)

Huntsman Cancer Institute at the University of Utah.

Seema Singhal (S)

Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Keith Stockerl-Goldstein (K)

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Carlyn Tan (C)

Fox Chase Cancer Center.

Donna Weber (D)

The University of Texas MD Anderson Cancer Center; and.

Alyse Johnson-Chilla (A)

National Comprehensive Cancer Network.

Jennifer Keller (J)

National Comprehensive Cancer Network.

Rashmi Kumar (R)

National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH